Brand Drugs
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Non-prescription Drugs Market Research Report 2023
1 Non-prescription Drugs Market Overview
1.1 Product Overview and Scope of Non-prescription Drugs
1.2 Non-prescription Drugs Segment by Type
1.2.1 Global Non-prescription Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Brand Drugs
1.2.3 Generic Drug
1.3 Non-prescription Drugs Segment by Application
1.3.1 Global Non-prescription Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Non-prescription Drugs Market Size Estimates and Forecasts
1.4.1 Global Non-prescription Drugs Revenue 2017-2028
1.4.2 Global Non-prescription Drugs Sales 2017-2028
1.4.3 Non-prescription Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Non-prescription Drugs Market Competition by Manufacturers
2.1 Global Non-prescription Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Non-prescription Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Non-prescription Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Non-prescription Drugs Manufacturing Sites, Area Served, Product Type
2.5 Non-prescription Drugs Market Competitive Situation and Trends
2.5.1 Non-prescription Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Non-prescription Drugs Players Market Share by Revenue
2.5.3 Global Non-prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-prescription Drugs Retrospective Market Scenario by Region
3.1 Global Non-prescription Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Non-prescription Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Non-prescription Drugs Market Facts & Figures by Country
3.3.1 North America Non-prescription Drugs Sales by Country
3.3.2 North America Non-prescription Drugs Revenue by Country
3.3.3 the United States
3.3.4 Canada
3.4 Europe Non-prescription Drugs Market Facts & Figures by Country
3.4.1 Europe Non-prescription Drugs Sales by Country
3.4.2 Europe Non-prescription Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Non-prescription Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Non-prescription Drugs Sales by Region
3.5.2 Asia Pacific Non-prescription Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Non-prescription Drugs Market Facts & Figures by Country
3.6.1 Latin America Non-prescription Drugs Sales by Country
3.6.2 Latin America Non-prescription Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Non-prescription Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Non-prescription Drugs Sales by Country
3.7.2 Middle East and Africa Non-prescription Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Non-prescription Drugs Historic Market Analysis by Type
4.1 Global Non-prescription Drugs Sales Market Share by Type (2017-2022)
4.2 Global Non-prescription Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Non-prescription Drugs Price by Type (2017-2022)
5 Global Non-prescription Drugs Historic Market Analysis by Application
5.1 Global Non-prescription Drugs Sales Market Share by Application (2017-2022)
5.2 Global Non-prescription Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Non-prescription Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer Non-prescription Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Roche Non-prescription Drugs Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Sanofi Non-prescription Drugs Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Johnson & Johnson Non-prescription Drugs Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Merck & Co. (MSD)
6.5.1 Merck & Co. (MSD) Corporation Information
6.5.2 Merck & Co. (MSD) Description and Business Overview
6.5.3 Merck & Co. (MSD) Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Merck & Co. (MSD) Non-prescription Drugs Product Portfolio
6.5.5 Merck & Co. (MSD) Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Novartis Non-prescription Drugs Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 AbbVie
6.6.1 AbbVie Corporation Information
6.6.2 AbbVie Description and Business Overview
6.6.3 AbbVie Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 AbbVie Non-prescription Drugs Product Portfolio
6.7.5 AbbVie Recent Developments/Updates
6.8 Gilead Sciences
6.8.1 Gilead Sciences Corporation Information
6.8.2 Gilead Sciences Description and Business Overview
6.8.3 Gilead Sciences Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Gilead Sciences Non-prescription Drugs Product Portfolio
6.8.5 Gilead Sciences Recent Developments/Updates
6.9 GlaxoSmithKline (GSK)
6.9.1 GlaxoSmithKline (GSK) Corporation Information
6.9.2 GlaxoSmithKline (GSK) Description and Business Overview
6.9.3 GlaxoSmithKline (GSK) Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 GlaxoSmithKline (GSK) Non-prescription Drugs Product Portfolio
6.9.5 GlaxoSmithKline (GSK) Recent Developments/Updates
6.10 Amgen
6.10.1 Amgen Corporation Information
6.10.2 Amgen Description and Business Overview
6.10.3 Amgen Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Amgen Non-prescription Drugs Product Portfolio
6.10.5 Amgen Recent Developments/Updates
6.11 AstraZeneca
6.11.1 AstraZeneca Corporation Information
6.11.2 AstraZeneca Non-prescription Drugs Description and Business Overview
6.11.3 AstraZeneca Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 AstraZeneca Non-prescription Drugs Product Portfolio
6.11.5 AstraZeneca Recent Developments/Updates
6.12 Bristol-Myers Squibb
6.12.1 Bristol-Myers Squibb Corporation Information
6.12.2 Bristol-Myers Squibb Non-prescription Drugs Description and Business Overview
6.12.3 Bristol-Myers Squibb Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Bristol-Myers Squibb Non-prescription Drugs Product Portfolio
6.12.5 Bristol-Myers Squibb Recent Developments/Updates
6.13 Eli Lilly
6.13.1 Eli Lilly Corporation Information
6.13.2 Eli Lilly Non-prescription Drugs Description and Business Overview
6.13.3 Eli Lilly Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Eli Lilly Non-prescription Drugs Product Portfolio
6.13.5 Eli Lilly Recent Developments/Updates
6.14 Teva
6.14.1 Teva Corporation Information
6.14.2 Teva Non-prescription Drugs Description and Business Overview
6.14.3 Teva Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Teva Non-prescription Drugs Product Portfolio
6.14.5 Teva Recent Developments/Updates
6.15 Bayer
6.15.1 Bayer Corporation Information
6.15.2 Bayer Non-prescription Drugs Description and Business Overview
6.15.3 Bayer Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Bayer Non-prescription Drugs Product Portfolio
6.15.5 Bayer Recent Developments/Updates
6.16 Novo Nordisk
6.16.1 Novo Nordisk Corporation Information
6.16.2 Novo Nordisk Non-prescription Drugs Description and Business Overview
6.16.3 Novo Nordisk Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Novo Nordisk Non-prescription Drugs Product Portfolio
6.16.5 Novo Nordisk Recent Developments/Updates
6.17 Allergan
6.17.1 Allergan Corporation Information
6.17.2 Allergan Non-prescription Drugs Description and Business Overview
6.17.3 Allergan Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Allergan Non-prescription Drugs Product Portfolio
6.17.5 Allergan Recent Developments/Updates
6.18 Takeda
6.18.1 Takeda Corporation Information
6.18.2 Takeda Non-prescription Drugs Description and Business Overview
6.18.3 Takeda Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Takeda Non-prescription Drugs Product Portfolio
6.18.5 Takeda Recent Developments/Updates
6.19 Boehringer Ingelheim
6.19.1 Boehringer Ingelheim Corporation Information
6.19.2 Boehringer Ingelheim Non-prescription Drugs Description and Business Overview
6.19.3 Boehringer Ingelheim Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Boehringer Ingelheim Non-prescription Drugs Product Portfolio
6.19.5 Boehringer Ingelheim Recent Developments/Updates
6.20 Takeda
6.20.1 Takeda Corporation Information
6.20.2 Takeda Non-prescription Drugs Description and Business Overview
6.20.3 Takeda Non-prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Takeda Non-prescription Drugs Product Portfolio
6.20.5 Takeda Recent Developments/Updates
7 Non-prescription Drugs Manufacturing Cost Analysis
7.1 Non-prescription Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Non-prescription Drugs
7.4 Non-prescription Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Non-prescription Drugs Distributors List
8.3 Non-prescription Drugs Customers
9 Non-prescription Drugs Market Dynamics
9.1 Non-prescription Drugs Industry Trends
9.2 Non-prescription Drugs Market Drivers
9.3 Non-prescription Drugs Market Challenges
9.4 Non-prescription Drugs Market Restraints
10 Global Market Forecast
10.1 Non-prescription Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Non-prescription Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Non-prescription Drugs by Type (2023-2028)
10.2 Non-prescription Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Non-prescription Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Non-prescription Drugs by Application (2023-2028)
10.3 Non-prescription Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Non-prescription Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Non-prescription Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Non-prescription Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Non-prescription Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Non-prescription Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Non-prescription Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Non-prescription Drugs Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Non-prescription Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Non-prescription Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Non-prescription Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Non-prescription Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Non-prescription Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Non-prescription Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Non-prescription Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-prescription Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Non-prescription Drugs Sales by Region (2017-2022) & (K Units)
Table 16. Global Non-prescription Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Non-prescription Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Non-prescription Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Non-prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 20. North America Non-prescription Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Non-prescription Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Non-prescription Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Non-prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 24. Europe Non-prescription Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Non-prescription Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Non-prescription Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Non-prescription Drugs Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Non-prescription Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Non-prescription Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Non-prescription Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Non-prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Non-prescription Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Non-prescription Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Non-prescription Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Non-prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Non-prescription Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Non-prescription Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Non-prescription Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Non-prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Global Non-prescription Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Non-prescription Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Non-prescription Drugs Revenue Share by Type (2017-2022)
Table 43. Global Non-prescription Drugs Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Non-prescription Drugs Sales (K Units) by Application (2017-2022)
Table 45. Global Non-prescription Drugs Sales Market Share by Application (2017-2022)
Table 46. Global Non-prescription Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Non-prescription Drugs Revenue Share by Application (2017-2022)
Table 48. Global Non-prescription Drugs Price by Application (2017-2022) & (USD/Unit)
Table 49. Pfizer Corporation Information
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Pfizer Non-prescription Drugs Product
Table 53. Pfizer Recent Developments/Updates
Table 54. Roche Corporation Information
Table 55. Roche Description and Business Overview
Table 56. Roche Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Roche Non-prescription Drugs Product
Table 58. Roche Recent Developments/Updates
Table 59. Sanofi Corporation Information
Table 60. Sanofi Description and Business Overview
Table 61. Sanofi Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Sanofi Non-prescription Drugs Product
Table 63. Sanofi Recent Developments/Updates
Table 64. Johnson & Johnson Corporation Information
Table 65. Johnson & Johnson Description and Business Overview
Table 66. Johnson & Johnson Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Johnson & Johnson Non-prescription Drugs Product
Table 68. Johnson & Johnson Recent Developments/Updates
Table 69. Merck & Co. (MSD) Corporation Information
Table 70. Merck & Co. (MSD) Description and Business Overview
Table 71. Merck & Co. (MSD) Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Merck & Co. (MSD) Non-prescription Drugs Product
Table 73. Merck & Co. (MSD) Recent Developments/Updates
Table 74. Novartis Corporation Information
Table 75. Novartis Description and Business Overview
Table 76. Novartis Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Novartis Non-prescription Drugs Product
Table 78. Novartis Recent Developments/Updates
Table 79. AbbVie Corporation Information
Table 80. AbbVie Description and Business Overview
Table 81. AbbVie Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. AbbVie Non-prescription Drugs Product
Table 83. AbbVie Recent Developments/Updates
Table 84. Gilead Sciences Corporation Information
Table 85. Gilead Sciences Description and Business Overview
Table 86. Gilead Sciences Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Gilead Sciences Non-prescription Drugs Product
Table 88. Gilead Sciences Recent Developments/Updates
Table 89. GlaxoSmithKline (GSK) Corporation Information
Table 90. GlaxoSmithKline (GSK) Description and Business Overview
Table 91. GlaxoSmithKline (GSK) Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. GlaxoSmithKline (GSK) Non-prescription Drugs Product
Table 93. GlaxoSmithKline (GSK) Recent Developments/Updates
Table 94. Amgen Corporation Information
Table 95. Amgen Description and Business Overview
Table 96. Amgen Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Amgen Non-prescription Drugs Product
Table 98. Amgen Recent Developments/Updates
Table 99. AstraZeneca Corporation Information
Table 100. AstraZeneca Description and Business Overview
Table 101. AstraZeneca Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. AstraZeneca Non-prescription Drugs Product
Table 103. AstraZeneca Recent Developments/Updates
Table 104. Bristol-Myers Squibb Corporation Information
Table 105. Bristol-Myers Squibb Description and Business Overview
Table 106. Bristol-Myers Squibb Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Bristol-Myers Squibb Non-prescription Drugs Product
Table 108. Bristol-Myers Squibb Recent Developments/Updates
Table 109. Eli Lilly Corporation Information
Table 110. Eli Lilly Description and Business Overview
Table 111. Eli Lilly Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Eli Lilly Non-prescription Drugs Product
Table 113. Eli Lilly Recent Developments/Updates
Table 114. Teva Corporation Information
Table 115. Teva Description and Business Overview
Table 116. Teva Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Teva Non-prescription Drugs Product
Table 118. Teva Recent Developments/Updates
Table 119. Bayer Corporation Information
Table 120. Bayer Description and Business Overview
Table 121. Bayer Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Bayer Non-prescription Drugs Product
Table 123. Bayer Recent Developments/Updates
Table 124. Novo Nordisk Corporation Information
Table 125. Novo Nordisk Description and Business Overview
Table 126. Novo Nordisk Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. Novo Nordisk Non-prescription Drugs Product
Table 128. Novo Nordisk Recent Developments/Updates
Table 129. Allergan Corporation Information
Table 130. Allergan Description and Business Overview
Table 131. Allergan Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. Allergan Non-prescription Drugs Product
Table 133. Allergan Recent Developments/Updates
Table 134. Takeda Corporation Information
Table 135. Takeda Description and Business Overview
Table 136. Takeda Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. Takeda Non-prescription Drugs Product
Table 138. Takeda Recent Developments/Updates
Table 139. Boehringer Ingelheim Corporation Information
Table 140. Boehringer Ingelheim Description and Business Overview
Table 141. Boehringer Ingelheim Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Boehringer Ingelheim Non-prescription Drugs Product
Table 143. Boehringer Ingelheim Recent Developments/Updates
Table 144. Takeda Corporation Information
Table 145. Takeda Description and Business Overview
Table 146. Takeda Non-prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 147. Takeda Non-prescription Drugs Product
Table 148. Takeda Recent Developments/Updates
Table 149. Production Base and Market Concentration Rate of Raw Material
Table 150. Key Suppliers of Raw Materials
Table 151. Non-prescription Drugs Distributors List
Table 152. Non-prescription Drugs Customers List
Table 153. Non-prescription Drugs Market Trends
Table 154. Non-prescription Drugs Market Drivers
Table 155. Non-prescription Drugs Market Challenges
Table 156. Non-prescription Drugs Market Restraints
Table 157. Global Non-prescription Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 158. Global Non-prescription Drugs Sales Market Share Forecast by Type (2023-2028)
Table 159. Global Non-prescription Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 160. Global Non-prescription Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 161. Global Non-prescription Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 162. Global Non-prescription Drugs Sales Market Share Forecast by Application (2023-2028)
Table 163. Global Non-prescription Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 164. Global Non-prescription Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 165. Global Non-prescription Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 166. Global Non-prescription Drugs Sales Market Share Forecast by Region (2023-2028)
Table 167. Global Non-prescription Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 168. Global Non-prescription Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-prescription Drugs
Figure 2. Global Non-prescription Drugs Market Share by Type in 2021 & 2028
Figure 3. Brand Drugs Product Picture
Figure 4. Generic Drug Product Picture
Figure 5. Global Non-prescription Drugs Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Global Non-prescription Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Non-prescription Drugs Market Size (2017-2028) & (US$ Million)
Figure 11. Global Non-prescription Drugs Sales (2017-2028) & (K Units)
Figure 12. Non-prescription Drugs Sales Share by Manufacturers in 2021
Figure 13. Global Non-prescription Drugs Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Non-prescription Drugs Players: Market Share by Revenue in 2021
Figure 15. Non-prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Non-prescription Drugs Sales Market Share by Region (2017-2022)
Figure 17. Global Non-prescription Drugs Sales Market Share by Region in 2021
Figure 18. Global Non-prescription Drugs Revenue Market Share by Region (2017-2022)
Figure 19. Global Non-prescription Drugs Revenue Market Share by Region in 2021
Figure 20. the United States Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. UK Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Non-prescription Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Non-prescription Drugs by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Non-prescription Drugs
Figure 44. Manufacturing Process Analysis of Non-prescription Drugs
Figure 45. Non-prescription Drugs Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Roche Sanofi Johnson & Johnson Merck & Co. (MSD) Novartis AbbVie Gilead Sciences GlaxoSmithKline (GSK) Amgen AstraZeneca Bristol-Myers Squibb Eli Lilly Teva Bayer Novo Nordisk Allergan Takeda Boehringer Ingelheim Takeda